Thomas Dayspring/LinkedIn
Jul 27, 2026, 16:57
Thomas Dayspring։ Could PCSK9 Inhibitors Reduce the Risk of Retinal Vascular Occlusions?
Thomas Dayspring, Lipid Specialist, Educator at Early Medical, shared a post on LinkedIn about a recent article by Isabella H. Yazji et al, published in American Journal of Ophthalmology, adding:
”Of interest – The Impact of PCSK9 Inhibitors on Development of Retinal Vascular Occlusions.”
Title: The Impact of PCSK9 Inhibitors on Development of Retinal Vascular Occlusions
Authors: Isabella H. Yazji, Nadia J. Abbass, David C. Kaelber, Katherine E. Talcott, Rishi P. Singh
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 27, 2026, 17:29Muhammad Numan: Normal MCV Does Not Exclude B12 Deficiency
-
Jul 27, 2026, 17:15ISTH 2026 Congress Paris Opens with a Powerful Message: Science Beyond Border
-
Jul 27, 2026, 17:14Michael Ombrello։ Decoding How Autoantibodies Cause Disease
-
Jul 27, 2026, 16:53Arun V. J.: How to Find a Mentor When You Know No One
-
Jul 27, 2026, 16:45Urtė Cholinaitė: A Meaningful Experience at the Lithuania Hemophilia Society Summer Camp
-
Jul 27, 2026, 16:33Martyna Lewand: Major Immunology Deal Brings FB102 to argenx
-
Jul 27, 2026, 16:30Jean Amiral: Laboratory differentiation of HIT, VITT and PF4 dependent Thrombocytopenias
-
Jul 27, 2026, 15:40Afila Thasnim: Blood Crossmatching Challenges and Safe Transfusion Decisions
-
Jul 27, 2026, 14:30William McKeown Elected Vice-President of the EHC